Forte Biosciences
FBRX
34 hedge funds and large institutions have $15.5M invested in Forte Biosciences in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.
2,500% more call options, than puts
Call options by funds: $26K | Put options by funds: $1K
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
40% more capital invested
Capital invested by funds: $11.1M → $15.5M (+$4.45M)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
13% more funds holding
Funds holding: 30 → 34 (+4)
0.24% more ownership
Funds ownership: 1.84% → 2.08% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$71.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$8.62K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.82K |
| 4 |
Renaissance Technologies
New York
|
+$1.62K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$7.26K |
| 2 |
Jane Street
New York
|
-$7.13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.3K |
| 4 |
Two Sigma Advisers
New York
|
-$1.23K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$349 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $712 | – | – | – |
|
27
Russell Investments Group
London,
United Kingdom
| $372 | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $204 | +$14 | +1 | +11% |
|
|
29
UBS Group
Zurich,
Switzerland
| $120 | -$1.3K | -93 | -94% |
|
|
LWCFA
30
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| $118 | – | – | – |
|
|
RFG
31
REAP Financial Group
Austin,
Texas
| $80 | +$56 | +4 | New |
|
|
32
Bank of America
Charlotte,
North Carolina
| $17 | -$349 | -25 | -96% |
|
33
JP Morgan Chase
New York
| $14 | – | – | – |
|
34
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
35
Jane Street
New York
| – | -$7.13K | -431 | Closed |
|
FBRX Hedge Fund Activity: Q4 2023 in Review
34 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q4 2023, worth a combined $15.5M — up 40% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FBRX positions and 1 closed out — a net gain of 4 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $71.7K. The largest seller was Goldman Sachs, cutting an estimated $7.26K.
- 34 institutional investors held Forte Biosciences (FBRX) as of Q4 2023, up from 30 in Q3 2023.
- Funds reported $15.5M of Forte Biosciences stock for Q4 2023, up 40% quarter-over-quarter.
- 5 funds opened new Forte Biosciences positions in Q4 2023 and 1 closed out, a net change of +4 holders.
- The largest Forte Biosciences buyer in Q4 2023 was Geode Capital Management, an estimated $71.7K added.
- The largest Forte Biosciences seller in Q4 2023 was Goldman Sachs, an estimated $7.26K sold.
Based on aggregated 13F filings for Q4 2023.